Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Ototoxicity × Audiometry × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Ototoxicity 1 Neoplasms 1 Head and Neck Cancer Patients Treated With Radiotherapy 1

Interventions

Cisplatin 4 sodium thiosulfate 3 Methotrexate 2 Chemotherapy, Adjuvant 2 tempol 1 ebselen 1 Vorinostat 1 Vincristine 1 Thioctic Acid 1 Surveys and Questionnaires 1 Sodium Chloride 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Radiotherapy 1 Radiosurgery 1 Pantoprazole 1 Mental Status and Dementia Tests 1 Magnetic Resonance Spectroscopy 1 Hydroxymethylglutaryl-CoA Reductase Inhibitors 1 Hyaluronic Acid 1 Hearing Tests 1 Genetic Association Studies 1 Drug Therapy 1 Dexamethasone 1 Cyclophosphamide 1 Chemoradiotherapy 1 Carboplatin 1 Audiometry 1 Atorvastatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06957132 2025-05-04

RISP-OTOTOX

Gustave Roussy, Cancer Campus, Grand Paris

Phase NA Not yet recruiting

Ototoxicity, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡